Results 11 to 20 of about 24,575,655 (169)
The podoplanin-CLEC-2 axis inhibits inflammation in sepsis [PDF]
Sepsis is a life-threatening condition where exaggerated inflammatory responses lead to severe tissue damage. Here, Rayes and colleagues show that the interaction between podoplanin and its receptor CLEC-2 on platelets plays a critical role in limiting ...
Julie Rayes +9 more
doaj +7 more sources
A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction. [PDF]
Podoplanin, a transmembrane glycoprotein, is overexpressed in certain types of tumors and induces platelet aggregation by binding to C-type lectin-like receptor 2 (CLEC-2) on the platelet membrane. Activated platelets release granule components, which in
Nobuo Watanabe +10 more
doaj +3 more sources
The structure of CLEC-2: mechanisms of dimerization and higher-order clustering
The platelet C-type lectin-like receptor CLEC-2 drives inflammation-driven venous thrombosis in mouse models of thrombo-inflammatory disease with a minimal effect on hemostasis identifying it as a target for a new class of antiplatelet agent.
Ying Di +2 more
exaly +5 more sources
Roles of the CLEC-2–podoplanin interaction in tumor progression
Podoplanin is a type-I transmembrane sialomucin-like glycoprotein expressed on the surface of several kinds of tumor cells. The podoplanin receptor is a platelet activation receptor known as C-type lectin-like receptor 2 (CLEC-2), which has been ...
Katsue Suzuki-Inoue
doaj +4 more sources
Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist. [PDF]
AbstractBackground CLEC-2 is a platelet receptor with an important role in thromboinflammation but a minor role in hemostasis. Two endogenous ligands of CLEC-2 have been identified, the transmembrane protein podoplanin and iron-containing porphyrin hemin, which is formed following hemolysis from red blood cells.
Morán LA +14 more
europepmc +5 more sources
Thrombomodulation via CLEC-2 targeting
CLEC-2 is a C-type lectin-like molecule that has recently been identified as a receptor on the surface of platelets. Ligand binding by CLEC-2 promotes phosphorylation of a tyrosine in the cytoplasmic domain YXXL motif of CLEC-2 by Src kinases and further downstream signalling events trigger platelet activation and aggregation.
O'Callaghan, CA +1 more
openaire +4 more sources
Low-dose Btk inhibitors selectively block platelet activation by CLEC-2 [PDF]
Inhibitors of the tyrosine kinase Btk have been proposed as novel antiplatelet agents. In this study we show that low concentrations of the Btk inhibitor ibrutinib block CLEC-2-mediated activation and tyrosine phosphorylation including Syk and PLCγ2 in ...
Phillip L.R. Nicolson +19 more
doaj +2 more sources
Das Hühner CLEC-2 Homolog [PDF]
Chicken CLEC-2 homologue: a thrombocyte receptor with activation function The chicken NKC was described to consist of only two C-type lectins, CD69 and a CD94/NKG2 hybrid, both encoded on chromosome 1. This study contributes to the characterisation of the chicken C-type lectin CD94/NKG2 by production of a specific monoclonal mab which was used to ...
Neulen, Marie-Luise
core +3 more sources
Evaluation of the podoplanin/C-type lectin-like receptor-2 (CLEC-2) pathway as a mediator of platelet and coagulation activation in sickle cell disease [PDF]
Background: Sickle cell disease (SCD) is a condition characterized by a prothrombotic state attributed to the simultaneous activation of hemostasis and innate immunity, referred to as thromboinflammation.
Ivanio Teixeira Borba-Junior +8 more
doaj +2 more sources
The Malayan pit viper, Calloselasma rhodostoma, produces a potent venom toxin, rhodocytin (aggretin) which causes platelet aggregation. Rhodocytin is a ligand for the receptor CLEC-2 on the surface of platelets.
Chris A O'Callaghan, Aleksandra A Watson
exaly +3 more sources

